Global Radiation Oncology Market 2021 Top Manufactures, Growth Opportunities and Investment Feasibility 2026
The market report, entitled
Global Radiation Oncology Market 2021 by Company, Regions, Type and Application, Forecast to 2026 aims to fill the need of organizations of settling on the best choices, deal with the marketing of goods or services, and accomplish better productivity. The report contains extensive research based on this market which inspects the intensive structure of the present market along with historical analysis. The report classifies the global Radiation Oncology market by type, application, country, and key manufacturers. A detailed analysis of the business scenario across the various regions and a review of the competitive dynamics covers a major portion of the study as it is essential in drafting future courses of action. The report also includes a critical understanding of notable developments and growth estimation across region
Join Reseller News
Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.Sign up now
Media releases are provided as is by companies and have not been edited or checked for accuracy. Any queries should be directed to the company itself.
21 May 2021 19:00
Oncology Information System Market Demand, Growth Challenges, Industry Analysis And Forecasts To 2029
Global oncology information system market was valued at USD 2,717 million in 2018 and is expected to grow at a CAGR of 7.7 % during the forecast period 2019–2026.
Oncology Information System Market 2021:
Research report provided by Straits Research is a detailed study of the
E-Mail
IMAGE: The experimental drug avasopasem manganese protects healthy tissue while enhancing radiation s capacity to kill cancerous tumor cells by converting superoxide to hydrogen peroxide. view more
Credit: Michael Story, Ph.D.
DALLAS - May 20, 2021 - An experimental drug that has shown promise in protecting healthy tissue from collateral damage caused by radiation therapy for cancer also appears to enhance radiation s capacity to kill tumors, a new study led by UT Southwestern scientists shows. The findings, published online in
Science Translational Medicine, could provide a much-needed boost to the radiation treatments used against a variety of tumor types.
The drug, avasopasem manganese (AVA), has already shown promise in clinical trials to prevent a side effect known as acute mucositis. This condition commonly occurs in head and neck cancer patients when radiation therapy damages mucous membranes. However, for this drug to become part of clinical care, it s
Sri Lankan gets top healthcare post in Australia-New Zealand Daily News (via HT Media Ltd.)
Professor Sanjaya Jeganathan, who is the president of the Royal Australian and New Zealand College of Radiologists (RANZCR), has been elected to the Chair of its Board of Directors.
Professor Sanjaya left Sri Lanka during the 1983 riots. He was elected to the post for a two years. He was described as an experienced and astute leader when he was appointed by Dr. Lance Lawler, who is the RANZCR President.
Prof Sanjay is a practising radiologist at the Perth Radiological Clinic and a consultant radiologist at Fiona Stanley Hospital and BreastScreen WA, with his roles spanning across Queensland, New Zealand, and Western Australia. He is serving his second term as Dean, Faculty of Clinical Radiology now.
The Radiosurgery Society® Establishes Residents Association to Optimize Educational Experience and Foster Future Leaders in SRS/SBRT prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.